Evolus (EOLS) Misses Q4 EPS by 6c; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts EOLS Hot Sheet
Join SI Premium – FREE
Evolus (NASDAQ: EOLS) reported Q4 EPS of ($0.23), $0.06 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $43.65 million versus the consensus estimate of $43.89 million.
GUIDANCE:
Evolus sees FY2023 revenue of $180-190 million, versus the consensus of $187.1 million.
For earnings history and earnings-related data on Evolus (EOLS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nurix Therapeutics, Inc. (NRIX) Reports Q3 EPS of $4.73
- BTIG sees S&P 500 ETF stock volume hit 22-year low on quiet calendar
- Truist Names Top Infrastructure Services Stocks
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
